Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Delpharm Buys 5 Famar Manufacturing Sites | Contract Pharma

What are you searching for?

Sign in
Breaking News

Delpharm Buys 5 Famar Manufacturing Sites

Facilities are located across France, Canada and the Netherlands.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

The French CDMO Delpharm has acquired five manufacturing sites belonging to Famar, in France, Canada and the Netherlands.  
 
The transaction covers the French sites located in Orléans (Loiret), L’Aigle (Orne) and Saint-Rémy-sur-Avre (Eure-et-Loire), as well as the Montreal site in Canada and that of Bladel in the Netherlands.

The group of sites together represents a turnover of €250 million and 1,300 employees. Including the revenues of the five additional sites, Delpharm will generate €750 million in turnover.
 
“This acquisition by Delpharm, a reputable CDMO, represents a great opportunity for the 1300 Famar colleagues and will allow the sites to foresee a fruitful and sustainable future,” said Patrick Puy, president, Famar.

Sébastien Aguettant, president, Delpharm, said, “With a headcount of 4700 people working at 17 manufacturing sites, Delpharm is reaching a new level and is now part of the top five CDMOs worldwide.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics